These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 10765089)
21. [Clinicopathologic features of renal cell carcinoma incidentally detected through radiological studies]. Bulnes Vázquez V; Alvarez-Múgica M; Fernández Gómez JM; Nava Tomás E; Jalón Monzón A; Meilán Martínez A Actas Urol Esp; 2008; 32(10):976-84. PubMed ID: 19143288 [TBL] [Abstract][Full Text] [Related]
22. [Computed tomography in the diagnosis of malignant renal neoplasms and their dissemination]. Palko A; Kun E; Greksa E; Khertelendi A Vestn Rentgenol Radiol; 1991; (2):37-40. PubMed ID: 1364778 [TBL] [Abstract][Full Text] [Related]
23. Serendipitous renal cell carcinoma in the post-CT era: continued evidence in improved outcomes. Leslie JA; Prihoda T; Thompson IM Urol Oncol; 2003; 21(1):39-44. PubMed ID: 12684126 [TBL] [Abstract][Full Text] [Related]
27. Computed tomography of renal cell carcinoma in patients with terminal renal impairment. Ferda J; Hora M; Hes O; Reischig T; Kreuzberg B; Mírka H; Ferdová E; Ohlídalová K; Baxa J; Urge T Eur J Radiol; 2007 Aug; 63(2):295-301. PubMed ID: 17324547 [TBL] [Abstract][Full Text] [Related]
28. The high rate of de novo graft carcinomas in renal transplant recipients. Viart L; Surga N; Collon S; Jaureguy M; Elalouf V; Tillou X Am J Nephrol; 2013; 37(2):91-6. PubMed ID: 23363786 [TBL] [Abstract][Full Text] [Related]
29. Incidental renal cell carcinoma: pathologic features and survival rate. Ou YC; Yang CR; Kuo JH; Kao YL; Cheng CL Zhonghua Yi Xue Za Zhi (Taipei); 1998 Feb; 61(2):71-6. PubMed ID: 9532868 [TBL] [Abstract][Full Text] [Related]
30. Application of contrast-enhanced ultrasonography after radiofrequency ablation for renal cell carcinoma: is it sufficient for assessment of therapeutic response? Kong WT; Zhang WW; Guo HQ; Qiu JL; Tang M; Jiang ZM; Shen Y; Li XG; Zhang SW Abdom Imaging; 2011 Jun; 36(3):342-7. PubMed ID: 21107560 [TBL] [Abstract][Full Text] [Related]
31. Conservative management of incidental contrast-enhancing renal masses as safe alternative to invasive therapy. Wehle MJ; Thiel DD; Petrou SP; Young PR; Frank I; Karsteadt N Urology; 2004 Jul; 64(1):49-52. PubMed ID: 15245934 [TBL] [Abstract][Full Text] [Related]
32. [Detection of renal cell carcinoma at health care center]. Terasawa Y; Fukuda Y; Suzuki Y; Morita M; Kato M; Suzuki K Nihon Hinyokika Gakkai Zasshi; 1992 Jan; 83(1):85-92. PubMed ID: 1564829 [TBL] [Abstract][Full Text] [Related]
34. Comparison of Contrast-Enhanced Ultrasound Scan (CEUS) and MRI in the follow-up of cryoablation for small renal tumors. Experience on 25 cases. Zeccolini G; Del Biondo D; Cicero C; Casarin A; Guarise A; Celia A Urologia; 2014; 81 Suppl 23():S1-8. PubMed ID: 24665032 [TBL] [Abstract][Full Text] [Related]
38. The role of contrast-enhanced ultrasound in the classification of CT-indeterminate renal lesions. Edenberg J; Gløersen K; Osman HA; Dimmen M; Berg GV Scand J Urol; 2016 Dec; 50(6):445-451. PubMed ID: 27609413 [TBL] [Abstract][Full Text] [Related]
39. A survey on incidental renal cell carcinoma in Japan. Aso Y; Homma Y J Urol; 1992 Feb; 147(2):340-3. PubMed ID: 1732589 [TBL] [Abstract][Full Text] [Related]
40. Incidental renal neoplasms: is there a need for routine screening? A Danish single-center epidemiological study. Rabjerg M; Mikkelsen MN; Walter S; Marcussen N APMIS; 2014 Aug; 122(8):708-14. PubMed ID: 24910251 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]